5-chloro-3-(3-methoxyphenyl)-1,2,4-oxadiazole, 95.0%, 500mg

4-Chloro-5-iodo-6-methylpyrimidine, 95.0%, 250mg

(R)-4-Benzyl-2-oxazolidinone, 98.0%, 25g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid, 95.0%, 250mg

Methyl 2-(4-formylphenyl)acetate, 98.0%, 1g

Bromotris(dimethylamino)phosphoniumhexafluorophosphate, 97.0%, 100g

trans-1,2-Cyclohexanedicarboxylic Acid>98.0%(GC)(T)500g

L(+)-tartaric acid, min. 99.5%, Ph.Eur., 25 kg, plastic packaging.

(3AR,4R,7AS)-TERT-BUTYL 4-(TERT-BUTOXYCARBONYLAMINO)HEXAHYDRO-1H-ISOINDOLE-2(3H)-CARBOXYLATE, 95.0%, 250mg

N-(2-ACETYLPHENYL)PENTANAMIDE, 95.0%, 2g

2,6-Bis(chloromethyl)pyridine, 98.0%, 5g

1-Chloro-5-fluoro-4-nitro-2-(trifluoromethyl)benzene, 98%, 5g

Bicyclo[2.2.1]heptan-2-ol, 95+%, 5g